{"id":"W2556627884","doi":"10.1182/blood.v124.21.486.486","title":"Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3-ITD+ Acute Myeloid Leukemia: A Report from the Children's Oncology Group","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Gemtuzumab ozogamicin; Medicine; Calicheamicin; CD33; Internal medicine; Oncology; Induction chemotherapy; Chemotherapy; Myeloid leukemia; Stem cell; CD34; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003298114,0.000203951,0.0002784891,0.0001685316,0.00009794471,0.0001721067,0.0001382251,0.0001784603,0.0004222438],"category_scores_gemma":[0.0004007318,0.00006509828,0.0003139964,0.0001627808,0.0001186062,0.0000835883,0.00007909248,0.0004784904,0.00005678182],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004393472,"about_ca_system_score_gemma":0.0002666352,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00189577,"about_ca_topic_score_gemma":0.003358281,"domain_scores_codex":[0.9999075,0.00003485966,0.00000953681,0.00001447703,0.00001877445,0.00001480629],"domain_scores_gemma":[0.99986,0.00005219728,0.00003297433,0.000009310466,0.00001286105,0.0000325532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.05521064,0.00497652,0.1176154,0.0004740499,0.001422762,0.0007118671,0.0001960516,0.001804407,0.0599485,0.000365428,0.01339878,0.7438756],"study_design_scores_gemma":[0.01860985,0.08119779,0.8360342,0.0001301292,0.002442462,0.002323367,0.0001370376,0.003400863,0.03025078,0.0002584959,0.02517563,0.00003938171],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875679,0.01042297,0.0002333144,0.0005323691,0.00004600015,0.00004942425,0.0001859625,0.00002861632,0.000933424],"genre_scores_gemma":[0.9946872,0.003650368,0.0004818631,0.0003239494,0.00006736682,0.00002448139,0.0003010847,0.000005997403,0.0004577349],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00189577,"threshold_uncertainty_score":0.003769517,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009803910134536695,"score_gpt":0.2724915109283486,"score_spread":0.2626876007938119,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}